These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35259534)

  • 1. As-Needed Use of Short-Acting β
    Rodríguez-Martínez CE; Sossa-Briceño MP; Buendia JA
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1562-1568. PubMed ID: 35259534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of ipratropium bromide for treating moderate to severe asthma exacerbations in pediatric patients in an emergency setting: A cost-effectiveness analysis.
    Rodriguez-Martinez CE; Sossa-Briceño MP; Buendia JA
    Pediatr Pulmonol; 2021 Dec; 56(12):3706-3713. PubMed ID: 34473916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
    Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
    Griffiths B; Ducharme FM
    Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial.
    Martinez FD; Chinchilli VM; Morgan WJ; Boehmer SJ; Lemanske RF; Mauger DT; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bade E; Covar RA; Friedman NJ; Guilbert TW; Heidarian-Raissy H; Kelly HW; Malka-Rais J; Mellon MH; Sorkness CA; Taussig L
    Lancet; 2011 Feb; 377(9766):650-7. PubMed ID: 21324520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantage of inhaled corticosteroids as additional therapy to systemic corticosteroids for pediatric acute asthma exacerbations: a cost-effectiveness analysis.
    Rodriguez-Martinez CE; Sossa-Briceño MP; Castro-Rodriguez JA
    J Asthma; 2020 Sep; 57(9):949-958. PubMed ID: 31164017
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program.
    Cloutier MM; Dixon AE; Krishnan JA; Lemanske RF; Pace W; Schatz M
    JAMA; 2020 Dec; 324(22):2301-2317. PubMed ID: 33270095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
    FitzGerald JM; Arnetorp S; Smare C; Gibson D; Coulton K; Hounsell K; Golam S; Sadatsafavi M
    Respir Med; 2020 Sep; 171():106079. PubMed ID: 32917353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of inhaled corticosteroids on an intermittent or as-needed basis in pediatric asthma: a systematic review of the literature.
    Rodriguez-Martinez CE; Sossa-Briceño MP; Garcia-Marcos L
    J Asthma; 2022 Nov; 59(11):2189-2200. PubMed ID: 34806537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial.
    Wilson EC; Price D; Musgrave SD; Sims EJ; Shepstone L; Murdoch J; Mugford HM; Blyth A; Juniper EF; Ayres JG; Wolfe S; Freeman D; Gilbert RF; Hillyer EV; Harvey I
    Pharmacoeconomics; 2010; 28(7):597-608. PubMed ID: 20446755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma.
    Buendía JA; Patiño DG
    BMC Pulm Med; 2021 Dec; 21(1):397. PubMed ID: 34865628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid plus β
    Wang G; Zhang X; Zhang HP; Wang L; Kang Y; Barnes PJ; Wang G
    Respir Res; 2017 Dec; 18(1):203. PubMed ID: 29207999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children].
    Rely K; McQuire SE; Alexandre PK; Escudero GS
    Value Health; 2011; 14(5 Suppl 1):S43-7. PubMed ID: 21839898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.